FIELD: medicine. SUBSTANCE: method involves producing fixed endometrial curettage preparations, determining the number of apoptotic cells and cells showing pathologic mitosis manifestations in percent to total number of gland epithelium cells, calculating metaphase- to-prophase ratio in gland epithelium nuclei. Apoptotic cell number making up 0.64%, pathologic mitosis number making up 0.68%, and metaphase-to-prophase ratio being equal to or greater than 0.48, gland cyst hyperplasia is considered to be the case. EFFECT: high accuracy of diagnosis. 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EARLIER DIAGNOSTICS OF BENIGN HYPERPLASTIC ENDOMETRIAL PROCESSES | 2000 |
|
RU2190221C2 |
| ULTRASONIC DIAGNOSIS METHOD FOR DETERMINING HYPERPLASTIC PROCESSES IN ENDOMETRIUM | 2004 |
|
RU2267993C1 |
| METHOD FOR DIAGNOSING ENDOMETRIOSIS OF THE UTERUS | 0 |
|
SU1751674A1 |
| METHOD FOR PREDICTION OF RISK OF HYPERPLASTIC PROCESSES OF ENDOMETRIUM | 2014 |
|
RU2557977C1 |
| METHOD FOR TREATING HYPERPLASTIC PROCESSES IN ENDOMETRIUM | 2001 |
|
RU2214823C2 |
| METHOD AND REMEDY FOR TREATING BENIGN HYPERPLASIA PROCESSES IN ENDOMETRIUM | 2004 |
|
RU2275194C1 |
| METHOD OF DIAGNOSING HYPERPLASTIC PROCESSES AND ENDOMETRIUM CANCER | 1995 |
|
RU2127429C1 |
| METHOD OF OVARY THECOMATOSIS DIAGNOSTICS DURING MENOPAUSE | 2010 |
|
RU2438581C1 |
| EARLY DIAGNOSIS METHOD FOR DETECTING LOW-DIFFERENTIATED ENDOMETRIAL ADENOCARCINOMA | 2004 |
|
RU2268472C1 |
| METHOD FOR TREATING PATIENTS FOR INTERNAL ENDOMETRIOSIS (ADENOMYOSIS) | 2003 |
|
RU2243009C1 |
